The body is now recommending lifting the suspension on the Sisonke study but says there should be better screening and monitoring of participants at high risk of blood clotting disorders.
The regulator also says all participants should be informed about the risk of developing the disorder.Six women there developed a blood clotting disorder after receiving the Johnson & Johnson vaccine.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: